by Kall Kwik WGC | Mar 9, 2016 | Free Library
February, 2016 SMM-140 Under Pressure There are six inexorable forces shaping the evolution of pharma and medtech. Asking and answering the questions about what selection pressures are acting in our industry is the first step in predicting how...
by Kall Kwik WGC | Mar 9, 2016 | Free Library
February, 2016 SMM-139 J&J’s Portent of Purity There is a new pattern of shareholder pressure across the sector, leading to new corporate structures being seen to emerge.
by Kall Kwik WGC | Jan 26, 2016 | Free Library
January, 2016 SMM-138 Not as we know it When it comes to evolution in industry, we need to think bout how the patient need will be met in future and evolve accordingly.
by Kall Kwik WGC | Jan 6, 2016 | Free Library
December, 2015 SMM-137 The Future of Pfizer(s) The media is full of the Pfizer-Allergan deal, especially the likely break up of the post-merger company into ‘innovative’ and ‘mature’ products. But lacking in this frenzied coverage is any sort of...
by Kall Kwik WGC | Jan 6, 2016 | Free Library
October, 2015 SMM-136 Competing on Alignment SWOT is both the most powerful and least understood strategic management tool. Used correctly, it translates the outputs of many other market analyses into a small number of key issues. This very...
by Kall Kwik WGC | Nov 28, 2015 | Free Library
November, 2015 SMM-135 Escaping Wicked Problems Some management dilemmas defy logic; they seem unsolvable by any traditional, methodical approach. However, in some circumstances, collaborative consensus offers the best potential...
